USPTO serial 98270862
PMM
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- —
- Examiner
- NIEMANN, SHELBY LYNN
- Law office
- TMO LAW OFFICE 125
What this means
These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.
Need help with PMM?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Nicole Kinsely, Esq.
Nicole Kinsely, Esq. FOLEY HOAG LLP155 SEAPORT BOULEVARDBOSTON, MA 02210United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 042 | Software as a service (SaaS) services featuring software for collecting, managing, and analyzing pharmaceutical data, biologic data, medical device data, and clinical trial data; Providing medical and scientific research information in the field of pharmaceuticals, biologic preparations, medical devices, and clinical trials; Software as a service (SAAS) services featuring software for matching cancer patients with appropriate therapeutic options, approved treatments, and clinical trials; Software as a service (SaaS) services featuring software for use in database management in the field of pharmaceuticals, biologic preparations, medical devices, and clinical trials; Software as a service (SaaS) services featuring software for management of clinical trials, namely, for planning clinical trials, identifying and recruiting patients for participation in clinical trials, and matching patients with clinical trials; Providing pharmaceutical data, biologic data, medical device data, clinical trial data, and patient data, and analysis of such data, all for pharmaceutical research and development | ACTIVE | — |
| 044 | Providing on-line medical record analysis services designed to provide patients with custom tailored information about the range of possible therapies available, through medication, biologic preparations, medical devices, and clinical trials, for a defined set of symptoms, diagnoses, and biological attributes; providing medical information in the field of pharmaceuticals, biologic preparations, medical devices, and clinical trials | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Apr 9, 2026 | MAB2 | ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Apr 9, 2026 | ABN2 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Oct 4, 2024 | XELG | APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED | — |
| Oct 4, 2024 | XELR | APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED | — |
| Jul 10, 2024 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 10, 2024 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 10, 2024 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 20, 2024 | DOCK | ASSIGNED TO EXAMINER | — |
| Dec 20, 2023 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Nov 18, 2023 | NWAP | NEW APPLICATION ENTERED | — |